Announcements Trials

Browse Landscape

Phase

Phase 1/2 1 Phase 1 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Leukemia, Myeloid, Acute 66 Myelodysplastic Syndromes 38 Leukemia, Myelomonocytic, Chronic 26 Leukemia 14 Myeloproliferative Disorders 10 Recurrence 7 Lymphoma 7 Hematologic Neoplasms 7 Neoplasms 6 Primary Myelofibrosis 5 Multiple Myeloma 5 Precursor Cell Lymphoblastic Leukemia-Lymphoma 3 Neoplasm, Residual 3 Myelodysplastic-Myeloproliferative Diseases 3 Lymphoma, T-Cell, Peripheral 3 Lymphoma, Non-Hodgkin 3 Lymphoma, Large B-Cell, Diffuse 3 Colorectal Neoplasms 3 Carcinoma, Non-Small-Cell Lung 3 Breast Neoplasms 3 Prostatic Neoplasms 2 Pancreatic Neoplasms 2 Neoplasm Metastasis 2 Melanoma 2 Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 2 Leukemia, Megakaryoblastic, Acute 2 Leukemia, Erythroblastic, Acute 2 Glioblastoma 2 Carcinoma, Renal Cell 2 Anemia, Refractory, with Excess of Blasts 2

Interventions

pembrolizumab 6 aldesleukin 6 Cyclophosphamide 6 fludarabine phosphate 5 fludarabine 5 Nivolumab 4 durvalumab 3 Sorafenib 3 Radiotherapy 3 Filgrastim 3 Everolimus 3 Axitinib 3 Temozolomide 2 Peripheral Blood Stem Cell Transplantation 2 Isotretinoin 2 Ipilimumab 2 Interleukin-2 2 Interferon-alpha 2 Fluorouracil 2 Dexamethasone 2 Cyclosporine 2 Bevacizumab 2 vorolanib 1 tremelimumab 1 tocilizumab 1 talazoparib 1 spartalizumab 1 sargramostim 1 poly ICLC 1 palbociclib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1/2 × Kidney Neoplasms × Azacitidine × Clear all

NCT00934440 2017-06-14

5-AZ

University of Kansas Medical Center

Phase 1/2 Terminated

11 enrolled 10 charts

Carcinoma, Renal Cell, Kidney Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡